Concepedia

Chrystia M. Zobniw

CM

10

Publications

1.9K

Citations

10

H-Index

2013

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Assiut University Hospitals

Ochsner Health System

Harvard University

Chrystia M. Zobniw is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunotherapy, and tumor immunity.

ORCID

Top concepts

Publications per year

2013–2023

10

Publications

10

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan et al. · Science · 2021 · 804 citations · Full text

, , +28

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Yared Hailemichael, Daniel H. Johnson, Noha Abdel‐Wahab et al. · Cancer Cell · 2022 · 314 citations · Full text

, , +5

Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis

Yinghong Wang, Hamzah Abu‐Sbeih, Emily Mao et al. · Inflammatory Bowel Diseases · 2018 · 238 citations

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

Daniel H. Johnson, Chrystia M. Zobniw, Van Anh Trinh et al. · Journal for ImmunoTherapy of Cancer · 2018 · 185 citations · Full text

IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy

Daniel H. Johnson, Anisha B. Patel, Marc Uemura et al. · Cancer Immunology Research · 2019 · 110 citations · Full text

Rows per page

1–5 of 10